Taipei Exchange - Delayed Quote TWD

NatureWise Biotech & Medicals Corporation (4732.TWO)

19.75
-0.55
(-2.71%)
At close: 2:26:16 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Zhong Yang Huang Chairman & Acting President -- -- --
Jun Kai Chen Chief Financial Officer and Assistant Vice President -- -- --
Xing Ling Cai Marketing Manager -- -- --
Nian Ci Hong Treasurer & Audit Office Manager -- -- --

NatureWise Biotech & Medicals Corporation

No. 36, Bade Road
6F Section 3
Taipei, 105
Taiwan
886 2 2570 6300 https://www.naturewise.com.tw
Sector: 
Healthcare
Industry: 
Biotechnology

Description

NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; PPL Taiwan green propolis; and NBM-BMX, an oral softgel capsule to treat cancer. The company was founded in 2000 and is based in Taipei, Taiwan.

Corporate Governance

NatureWise Biotech & Medicals Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

August 27, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers